Quaker Chemical Earnings Call Highlights Growth, Cost Push

Quaker Chemical ((KWR)) has held its Q1 earnings call. Read on for the main highlights of the call.

Quaker Chemical’s latest earnings call struck a mainly upbeat tone, with management highlighting solid top-line growth, sustained market share gains and a stronger balance sheet. While margins were squeezed by higher input and shipping costs, executives framed these as temporary headwinds and laid out a detailed cost-cutting plan they say will restore profitability in the coming quarters.

Revenue Growth and Earnings Improvement

Quaker Chemical reported net sales of $480 million, up 8% year over year, supported by 3% organic volume growth and contributions from acquisitions. Adjusted EBITDA rose 5% to $73 million and non‑GAAP diluted EPS increased 3% to $1.63, showing earnings expansion despite margin pressure.

Market Share Gains Against Weak End Markets

The company posted net share gains of 4%, at the top of its target range, marking the 10th straight quarter of taking share. Management stressed that Quaker outgrew its end markets, which they estimate declined about 1% in the period, underscoring competitive strength in a soft macro backdrop.

Asia Pacific Leads with Strong Outperformance

Asia Pacific remained the standout region, with sales up roughly 25% year over year, driven by about 10% organic volume growth, the Dipsol deal and favorable foreign exchange near 3%. Segment earnings surged around 32%, adding about $8 million, as the region benefited from higher demand and scale efficiencies.

Gross Margin Moves Toward Target Range

Gross margin improved sequentially by about 150 basis points and was roughly 40 basis points higher than a year ago, coming in near 36.8%. That level sits toward the high end of Quaker’s 36%–37% target range and reflects better asset utilization and stronger operational execution across the network.

Balance Sheet and Liquidity Reinforced

Management emphasized a healthier financing profile after amending the credit agreement, extending the nearest maturity from 2027 to April 2031 and adding around $300 million in revolving capacity with a further upsizing option. The company’s cost of debt sits near 5%, and interest expense held steady at about $10 million in the quarter.

Transformation Program Targets Structural Savings

Quaker unveiled a transformation initiative aimed at cutting cost and complexity, with roughly $10 million of new run‑rate savings expected by the end of 2026. Overall, management sees a clear path to at least $20 million to $30 million of sustainable structural savings over three years, including benefits from closing the Dortmund site.

Acquisition Synergies and Portfolio Expansion

Acquisitions, led by the Dipsol transaction, contributed about 4% to first‑quarter net sales and will be folded into the organic base from the second quarter. Executives said integration is progressing well and that synergies and a broader product lineup are helping drive additional share gains, especially in Asia.

Disciplined Capex and Strategic Investments

Capital spending was around $11 million in the quarter, mainly tied to a new facility in China that should boost efficiency and local manufacturing capabilities. Quaker reiterated that full‑year 2026 capex should remain disciplined at about 2.5% to 3.5% of sales, balancing growth investments with cash preservation.

Short‑Term Gross Margin Pressure Ahead

Despite recent improvements, management warned that second‑quarter gross margin will likely fall about 200 to 300 basis points from Q1 levels. The drag stems from raw material and shipping cost inflation linked to the conflict in the Middle East, though the company expects the impact to be temporary if conditions do not worsen.

EBITDA Margin Below Target as SG&A Rises

Adjusted EBITDA margin slipped to 15.1%, still meaningfully below the company’s longer‑term goal of above 18%. Selling, general and administrative expenses climbed roughly $16 million, or 14% year over year, driven by acquisitions, currency, higher incentive pay and accelerated depreciation, with organic SG&A up 6%.

Americas Face Volume and Margin Challenges

In the Americas, organic volumes fell slightly and segment earnings dropped by about $5 million, an 8% decline from a year earlier. Management cited a lingering customer outage, tariff uncertainty and weather‑related disruptions as key factors behind the region’s softer performance and compressed margins.

Unfavorable Pricing and Product Mix Effects

Company‑wide selling price and product mix were a roughly 3% headwind, with Asia price and mix down about 2%, as lower index pricing and regional mix offset volume gains. These dynamics partially diluted the benefit from acquisitions and underlying volume growth, weighing on reported revenue quality.

Operating Cash Flow and Restructuring Costs

Operating cash flow came in at $4 million, seasonally low but an improvement from a $3 million use of cash in the prior‑year quarter. The period also included about $4 million of cash restructuring costs, reflecting the upfront spend tied to the transformation and footprint optimization actions.

Raw Material Inflation and Pricing Lag Risk

All major raw material categories, including base oils, additives and oleochemicals, are seeing cost inflation closely linked to crude prices. Because much of Quaker’s pricing is index‑based with contractual lags, management expects a timing gap where higher costs hit margins before price increases fully flow through.

Geopolitical Conflict as an Ongoing Overhang

Direct sales exposure to the Middle East and North Africa remains under 2% of 2025 revenue, and the company has so far maintained supply continuity. However, executives cautioned that a prolonged conflict could bring broader demand softness and further input cost spikes, risks that are not fully embedded in their base‑case outlook.

Guidance and Outlook for Growth and Margin Recovery

Looking ahead, Quaker expects sequential volume and revenue growth in the second quarter alongside the anticipated gross‑margin dip from higher costs. Management still forecasts revenue and adjusted EBITDA growth for 2026, with gross margins returning to the 36%–37% band within one to two quarters and adjusted EBITDA margins trending toward or above 18% over time.

Quaker Chemical’s earnings call painted a story of steady growth and share gains tempered by near‑term margin and cost challenges. Investors were left with a mixed but generally constructive picture: short‑term profitability headwinds, but a stronger regional mix, a fortified balance sheet and a sizable cost‑reduction program underpinning the longer‑term earnings trajectory.